Drugs for treating urinary schistosomiasis (Q24241883)

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The impact of population level deworming on the haemoglobin levels of schoolchildren in Tanga, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Mixed Schistosoma haematobium and S. mansoni infection: effect of different treatments on the serum level of circulating anodic antigen (CAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Praziquantel: a new schistosomicide against Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Long-term efficacy of single-dose oral treatment in schistosomiasis haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

A simplified dosage schedule of metrifonate in the treatment of Schistosoma haematobium infection in Somalia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The potential of artemether for the control of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The reliability of self-reported blood in urine and schistosomiasis as indicators of Schistosoma haematobium infection in school children: a study in Muheza District, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

21 January 2018

Helminthic infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Applicability of a monoclonal antibody-based dipstick in diagnosis of urinary schistosomiasis in the Central Region of Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The global status of schistosomiasis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Antischistosomal drugs: past, present ... and future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Determinants of health-seeking behaviour for schistosomiasis-related symptoms in the context of integrating schistosomiasis control within the regular health services in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

A model for variations in single and repeated egg counts in schistosoma mansoni infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Validation of a chart to estimate true Schistosoma mansoni prevalences from simple egg counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The global epidemiological situation of schistosomiasis and new approaches to control and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Implementation of human schistosomiasis control: Challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Waterborne infectious diseases--could they be consigned to history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized, controlled trial in Kenyan school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Worm burdens in schistosome infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Schistosomiasis vaccines: a devils' advocate view

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

21 January 2018

Human schistosomiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Schistosomiasis control: keep taking the tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The use of ultrasound in schistosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Metrifonate. Summary of toxicological and pharmacological information available

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

From katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Human behavior, health education and schistosomiasis control: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Metrifonate for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The impact of a school health programme on the prevalence and morbidity of urinary schistosomiasis in Mwera Division, Pangani District, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Current status of vaccines for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Relation between intensity of Schistosoma haematobium infection and clinical haematuria and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Epidemiology of urinary bladder cancer: from tumor development to patient's death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Urinary schistosomiasis on Zanzibar: application of two novel assays for the detection of excreted albumin and haemoglobin in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Schistosoma mansoni: chemotherapy of infections of different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

21 January 2018

Schistosomiasis control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with schistosoma haematobium in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Bridges to sustainable tropical health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Low awareness of intestinal schistosomiasis in northern Senegal after 7 years of health education as part of intense control and research activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

4-Isothiocyanato-4'-nitrodiphenylamine (C 9333-Go/CGP 4540), an anthelminthic with an unusual spectrum of activity against intestinal nematodes, filariae and schistosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Conquering schistosomiasis in China: the long march

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

Interventions for treating schistosomiasis haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

A monoclonal antibody-based dipstick assay for diagnosis of urinary schistosomiasis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Treatment of urinary schistosomiasis. Practice and theory

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

The impact of schistosomiasis on human nutrition

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Proteinuria, hematuria, and leukocyturia in children with mixed urinary and intestinal schistosomiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

[Ultrasound diagnosis of bilharziasis]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Epidemiology of helminth infections: implications for parasite control programmes, a South African perspective.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Culture of Schistosoma haematobium in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Prophylaxis of schistosomiasis - field trial of metrifonate for the prevention of human infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Field trial of metrifonate in the treatment and prevention of schistosomiasis infection in man

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Praziquantel: is there real resistance and are there alternatives?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Infectious disease. Medical helminthology in the 21st century

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Single dose oral treatment in urinary schistosomiasis: a double blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Relationships of Schistosoma haematobium, hookworm and malarial infections and metrifonate treatment to growth of Kenyan school children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Relationships of Schistosoma hematobium, hookworm and malarial infections and metrifonate treatment to hemoglobin level in Kenyan school children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

The effect of metrifonate in mixed Schistosoma haematobium and Schistosoma mansoni infections in humans.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Single dose metrifonate or praziquantel treatment in Kenyan children. I. Effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haematobium and hookworm egg counts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

Efficacy of praziquantel against Schistosoma haematobium infection in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000053.PUB2

7 January 2021

10.1002/14651858.CD000053.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1291921

OpenCitations bibliographic resource ID

1291921

1 reference